期刊文献+

半乳凝集素-3在心力衰竭中的应用价值 被引量:1

Applied value of galectin-3 in the diagnosis and treatment of heart failure
下载PDF
导出
摘要 目的:探讨半乳凝集素-3(ga-3)在心力衰竭中的应用价值。方法:选取40例心力衰竭患者,治疗前后测定ga-3、脑钠肽(BNP)、Ⅰ型前胶原氨基末端肽(PⅠNP)、Ⅲ型前胶原氨基末端肽(PⅢNP)、高敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)水平,进行ga-3与BNP、PⅠNP、PⅢNP、hs-CRP、TNF-α、IL-6的相关关系分析。治疗1周后检查心脏彩超,测定射血分数(EF)、左室舒张末径(LVEDD),进行ga-3、BNP与超声心动图指标的相关分析。结果 :ga-3与BNP、PⅠNP、PⅢNP、hs-CRP、TNF-α、IL-6、LVEDD呈显著正相关(P<0.01,P<0.05)。ga-3、BNP与EF值呈显著负相关(P<0.01,P<0.05)。BNP与PⅠNP、PⅢNP均无显著相关性(均P>0.05)。结论:ga-3与心力衰竭患者炎性反应、心功能减退、心肌重构相关,ga-3可以预测心衰患者发生心室重构。 Objective:To evaluate applied value of galectin-3 (ga-3)in the diagnosis and treatment of heart failure.Methods:A total of 40 patients with heart failure was selected for this study.Their ga-3,BNP,P I NP,P mNP,hs-CRP,TNF-α and IL-6 levels were examined before and after treatment.The analyses of the relation- ship between ga-3 and BNP,P I NP,PⅢNP,hs-CRP,TNF-a,IL-6 were performed respeetively.Echocardiogra- phy was carried on for the patients 1 week after the treatment.The EF and LVEDD were measured,and the analysis of the relationship between ga-3,BNP and heart function,echocardiogram indicators were performed. Results:Correlation analysis showed that the serum levels of ga-3 and BNP,P I NP,PⅢNP,hs-CRP,TNF-α, IL-6,LVEDD had a positive correlation (P〈0.01,P〈0.05).Concusition analysis showed that the serum levels of ga-3,BNP and EF had a negative correlation (P〈0.01,P〈0.05).Conclusion:In patients with heart failure,the serum levels of ga-3 had a negative correlation with inflammatory reaction ,cardiac malfunction and myocardial remodeling.h can be used as a new biomarker for evaluation of myocardial remodeling in patients with heart failure.
出处 《中日友好医院学报》 2017年第6期342-344,共3页 Journal of China-Japan Friendship Hospital
基金 吉林省卫生计生委科技计划资助项目(20152082)
关键词 心力衰竭 半乳凝集素-3 炎性因子 心肌重构 heart failure galectin-3 inflammatory factor myocardial remodeling
  • 相关文献

参考文献2

二级参考文献13

  • 1Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused up- date incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Re- port of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guide- lines Developed in Collaboration With the International Soci- ety for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1-e90.
  • 2Nakahara S, Oka N, Wang Y, et al. Characterization of the nuclear import pathways of Galectin-3. Cancer Res 2006; 66: 9995-10006.
  • 3van Kimmenade RR, Januzzi JL Jr., Ellinor PT, et al. Utilityof amino-terminal pro-brain natriuretic peptide, Galectin-3, and apelin for the evaluation of patients with acute heart fail- ure. JAm Coll Cardio12006; 48: 1217-1224.
  • 4Lok D J, Van Der Meer P, de la Porte PW, et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin ResCardio12010; 99: 323-328.
  • 5Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res 2008; 58:88-111.
  • 6Ueland T, Aukmst P, Broch K, et al. Galectin-3 in heart fail- ure: high levels are associated with all cause mortality, lnt J Cardio12011; 150:361 364.
  • 7van der Velde AR, Gullestad L, Ueland T, et al. Prognostic value of changes in galectin-3 levels over time in patients with heart failure data from CORONA and COACH. Circ" Heart Fail 2013; 6: 219326.
  • 8Milting H, Ellinghaus P, Seewald M, et al. Plasma biomarkers of mycordial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transplant 2008; 27:589 596.
  • 9Grandin EW, Jarolim P, Murphy SA, et al. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22. Clin Chem 2012; 58: 267-273.
  • 10de Boer RA, Verweij N, van Veldhuisen D J, et al. A ge- home-wide association study of circulating galectin-3. PLoS ONE 2012; 7: e47385.

共引文献37

同被引文献20

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部